GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (OTCPK:CPHRF) » Definitions » Cyclically Adjusted PS Ratio

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Cyclically Adjusted PS Ratio : 5.84 (As of May. 22, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cipher Pharmaceuticals Cyclically Adjusted PS Ratio?

As of today (2024-05-22), Cipher Pharmaceuticals's current share price is $6.4792. Cipher Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $1.11. Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio for today is 5.84.

The historical rank and industry rank for Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio or its related term are showing as below:

CPHRF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.39   Med: 3   Max: 43
Current: 5.8

During the past years, Cipher Pharmaceuticals's highest Cyclically Adjusted PS Ratio was 43.00. The lowest was 0.39. And the median was 3.00.

CPHRF's Cyclically Adjusted PS Ratio is ranked worse than
83.29% of 742 companies
in the Drug Manufacturers industry
Industry Median: 2.13 vs CPHRF: 5.80

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cipher Pharmaceuticals's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.240. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $1.11 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cipher Pharmaceuticals Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Cyclically Adjusted PS Ratio Chart

Cipher Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.38 0.79 1.35 2.63 3.72

Cipher Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.22 2.37 2.79 3.72 5.94

Competitive Comparison of Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio falls into.



Cipher Pharmaceuticals Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=6.4792/1.11
=5.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipher Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Cipher Pharmaceuticals's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.24/126.2576*126.2576
=0.240

Current CPI (Mar. 2024) = 126.2576.

Cipher Pharmaceuticals Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.318 99.473 0.404
201409 0.252 99.394 0.320
201412 0.231 98.367 0.296
201503 0.278 99.789 0.352
201506 0.334 100.500 0.420
201509 0.321 100.421 0.404
201512 0.369 99.947 0.466
201603 0.262 101.054 0.327
201606 0.317 102.002 0.392
201609 0.291 101.765 0.361
201612 0.215 101.449 0.268
201703 0.301 102.634 0.370
201706 0.369 103.029 0.452
201709 0.374 103.345 0.457
201712 0.454 103.345 0.555
201803 0.169 105.004 0.203
201806 0.258 105.557 0.309
201809 0.179 105.636 0.214
201812 0.233 105.399 0.279
201903 0.190 106.979 0.224
201906 0.206 107.690 0.242
201909 0.215 107.611 0.252
201912 0.219 107.769 0.257
202003 0.218 107.927 0.255
202006 0.174 108.401 0.203
202009 0.176 108.164 0.205
202012 0.224 108.559 0.261
202103 0.201 110.298 0.230
202106 0.225 111.720 0.254
202109 0.167 112.905 0.187
202112 0.223 113.774 0.247
202203 0.206 117.646 0.221
202206 0.214 120.806 0.224
202209 0.187 120.648 0.196
202212 0.192 120.964 0.200
202303 0.191 122.702 0.197
202306 0.206 124.203 0.209
202309 0.236 125.230 0.238
202312 0.199 125.072 0.201
202403 0.240 126.258 0.240

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cipher Pharmaceuticals  (OTCPK:CPHRF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cipher Pharmaceuticals Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipher Pharmaceuticals (Cipher Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Headlines